Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Individuals taking medications for diabetes, thyroid disorders, or other metabolic conditions should use AOD-9604 only under medical supervision with appropriate monitoring
Intravenous AOD-9604 Early human studies used single intravenous amounts of 25-400 mcg/kg
Targeted Reduction of Stubborn Fat Deposits: AOD-9604 appears especially effective at mobilizing fat from areas resistant to traditional diet and exercise interventions
If effects continue at reduced doses, the peptide may not be right for you
This classification allows for their use only for research development and laboratory studies
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
